Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Ethrane Articles

India's Piramal buys Minrade in $40M deal

15 January 2009

Adeka debuts new anesthetic, other Minrad prods

23 June 2008

Minrad completes sevoflurane API line validation

17 December 2007

Abbott Labs UK receives special award for innovation

24 February 2003

Medeva Takes On Single Isomer Methylphenidate

27 January 1997

Medeva "Not For Sale" But Is On Track For Growth

24 July 1995

BOC Sues Medeva Over Inhalon" Trade Secrets"

10 April 1995

Medeva's 1994 Results Crown Five Years Of Growth

27 March 1995

Filing For Supplement To Albuterol ANDA

20 March 1995

Medeva Acquisition Of Inhalon On Right Track

23 January 1995

New Acquisition For Medeva In The USA

12 December 1994

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Elan makes "transformational" acquisitions and a divestment
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Elan makes "transformational" acquisitions and a divestment

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS